Answers are grounded in this paper and cite their sources.
Our data (1) confirm and extend previous observations that antiparanodal IgG2/3 but not IgG4 antibodies can occur in acute-onset neuropathies manifesting as monophasic GBS, (2) suggest association of IgG3 to a favorable response to IVIg, and (3) lend support to the hypothesis that in some patients, an IgG subclass switch from IgG3 to IgG4 may be the correlate of a secondary progressive or relapsing course following a GBS-like onset.
No takes yet. Share an insight, caveat, or question.
Appeltshauser et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: